Xiamen Kang Zhongyuan Biotechnology Co.

15 recalls Categories: Prescription Drugs, Other Drugs

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Mar 20, 2026 Prescription Drugs Nationwide View Details →

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Mar 20, 2026 Prescription Drugs Nationwide View Details →

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Mar 20, 2026 Prescription Drugs Nationwide View Details →

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Mar 20, 2026 Prescription Drugs Nationwide View Details →

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Mar 20, 2026 Prescription Drugs Nationwide View Details →

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.

Mar 20, 2026 Prescription Drugs Nationwide View Details →